Testing effectiveness (Phase 2)Study completedNCT02365610What this trial is testingGWP42006 in People With Focal Seizures - Part BWho this might be right forEpilepsyFocal Seizures Jazz Pharmaceuticals 162
Early research (Phase 1)Looking for participantsNCT07233239What this trial is testingEvaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset SeizuresWho this might be right forFocal Seizures Jazz Pharmaceuticals 100
Large-scale testing (Phase 3)Study completedNCT00050934What this trial is testingPediatric Epilepsy StudyWho this might be right forEpilepsyEpilepsies, Partial Novartis Pharmaceuticals 132
Post-approval studies (Phase 4)Study completedNCT00288639What this trial is testingLyrica (Pregabalin) Administered as an Add-on Therapy for Partial Seizures (LEADER).Who this might be right forEpilepsy Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 98
Not applicableStudy completedNCT00001932What this trial is testingSerotonin Receptors in Seizure DisordersWho this might be right forPartial Epilepsy National Institute of Neurological Disorders and Stroke (NINDS) 95
Large-scale testing (Phase 3)Study completedNCT00433667What this trial is testingThe Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.Who this might be right forEpilepsyEpilepsy, FocalSeizure Disorder+2 more SK Life Science, Inc. 563
Large-scale testing (Phase 3)Study completedNCT00150800What this trial is testingThis Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam TreatmentWho this might be right forEpilepsy UCB PHARMA Inc. (US) 668
Not applicableStudy completedNCT06960811What this trial is testingEpileptic Psychoses and Their Link With Ictal Emotions and ConsciousnessWho this might be right forEpilepsy With Partial Onset Seizures With or Without Secondary GeneralizationPsychosesEpilepsy, Generalized Central Hospital, Nancy, France 117
Large-scale testing (Phase 3)Ended earlyNCT00372528What this trial is testingAn Open-Label Study Of Pregabalin In Subjects With Refractory Partial SeizuresWho this might be right forEpilepsy Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 21
Testing effectiveness (Phase 2)Study completedNCT00800215What this trial is testingA Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927Who this might be right forEpilepsy UCB Pharma 60
Post-approval studies (Phase 4)Study completedNCT00266604What this trial is testingEvaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of EpilepsyWho this might be right forEpilepsySeizuresEpilepsies, Partial+2 more Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 409
Early research (Phase 1)Study completedNCT04903314What this trial is testingDose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset SeizuresWho this might be right forPartial Epilepsy SK Life Science, Inc. 26
Not applicableStudy completedNCT00001325What this trial is testingMetabolic Abnormalities in Children With EpilepsyWho this might be right forGeneralized EpilepsyInfantile SpasmsMetabolic Disease+2 more National Institute of Neurological Disorders and Stroke (NINDS) 80
Large-scale testing (Phase 3)Study completedNCT01261325What this trial is testingBrivaracetam Efficacy and Safety Study in Subjects With Partial Onset SeizuresWho this might be right forEpilepsy UCB Pharma 768
Not applicableStudy completedNCT03531008What this trial is testingHuman Epilepsy Project 2: Resistant Focal Seizures StudyWho this might be right forEpilepsyBrain DiseasesCentral Nervous System Diseases+2 more Epilepsy Foundation of America 157
Large-scale testing (Phase 3)Looking for participantsNCT05135091What this trial is testingStudy of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))Who this might be right forMesial Temporal Lobe Epilepsy Neurona Therapeutics 88
Testing effectiveness (Phase 2)Ended earlyNCT04153175What this trial is testingStudy to Assess Intracerebroventricular (ICV) Delivery of CT-010 in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary GeneralizationWho this might be right forRefractory Epilepsy Cerebral Therapeutics LLC 30
Not applicableStudy completedNCT04252846What this trial is testingInvestigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized EpilepsyWho this might be right forIdiopathic Generalized EpilepsyPartial Onset SeizuresGeneralised Tonic-Clonic Seizures Eisai Limited 191
Not applicableUnknownNCT00208520What this trial is testingSecond-Line Treatment Choice for EpilepsyWho this might be right forAdults With Tonic Clonic Seizures and/or Partial Seizures Dutch Epilepsy Clinics Foundation 60
Not applicableLooking for participantsNCT06657378What this trial is testingEvaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic SeizuresWho this might be right forPartial-Onset SeizuresPrimary Generalized Tonic-clonic Seizures Eisai Co., Ltd. 110